CRESO PHARMA LIMITED has not announced a capital raise, but we are collating interest in any future round. Pledge your support and we will let the company know of your interest.
Creso Pharma Limited (CPH) aims to develop register, and commercialize pharmaceutical-grade cannabis- and hemp-based products and treatments, to the highest GMP quality standards. Company's strategy is to leverage science and research to develop, register and commercialize new cannabis and hemp-derived therapeutic products based on solid scientific data. Company provide safe high grade CBD therapeutic products which are unique in composition, standardized in formulation and dose, and administered by proprietary delivery technologies which fulfill the necessary requirements for efficacy, safety, highest quality and consistency.
Level 1/1 Altona St, West Perth WA 6005, Australia